Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 23463744)

1.

Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.

Perelman M, Leake S.

Ann Pharmacother. 2013 Mar;47(3):428. doi: 10.1345/aph.1R069b. Epub 2013 Mar 5. No abstract available.

PMID:
23463744
2.

Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.

Grassin-Delyle S, Naline E, Devillier P.

Ann Pharmacother. 2013 Mar;47(3):427-8. doi: 10.1345/aph.1R069a. Epub 2013 Mar 5. No abstract available.

PMID:
23463741
3.

Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain. Authors' reply.

Dietrich E, Gums JG.

Ann Pharmacother. 2013 Mar;47(3):429. No abstract available.

PMID:
23463745
4.

Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.

Dietrich E, Gums JG.

Ann Pharmacother. 2012 Oct;46(10):1382-91. doi: 10.1345/aph.1R069. Epub 2012 Sep 25. Review.

PMID:
23012382
5.

Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.

Mercadante S, Prestia G, Adile C, Casuccio A.

J Pain. 2014 Jun;15(6):602-7. doi: 10.1016/j.jpain.2014.02.002. Epub 2014 Feb 19.

PMID:
24561001
6.

Fast-acting fentanyl preparations and pain management.

McWilliams K, Fallon M.

QJM. 2013 Oct;106(10):887-90. doi: 10.1093/qjmed/hct092. Epub 2013 Apr 22. Review.

7.

Patient satisfaction with intranasal fentanyl for breakthrough pain.

Veldhorst-Janssen NM, Fiddelers AA, Zandstra H, Kessels AG, Zandstra H, Marcus MA, Neef C, van der Kuy PH.

J Palliat Med. 2012 Jun;15(6):631-2. doi: 10.1089/jpm.2012.0013. No abstract available.

PMID:
22656053
8.

Are there cost benefits to fentanyl for breakthrough pain?

Davis MP.

J Pain Symptom Manage. 2012 Sep;44(3):e1-2. doi: 10.1016/j.jpainsymman.2012.06.002. No abstract available.

PMID:
22939453
9.

Fentanyl pectin nasal spray for breakthrough cancer pain.

Taylor DR, Gabrail N.

Future Oncol. 2012 Feb;8(2):121-30. doi: 10.2217/fon.11.146.

PMID:
22335576
10.

Fentanyl buccal film. New oral transmucosal form has no advantages in breakthrough pain.

[No authors listed]

Prescrire Int. 2013 Oct;22(142):237. No abstract available.

PMID:
24298583
11.

Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.

Kaessner N, Nave R, Roepcke S, Facius A, Lahu G.

Int J Clin Pharmacol Ther. 2012 Sep;50(9):665-77. doi: 10.5414/CP201737.

PMID:
22784611
12.

Optimal management of breakthrough cancer pain (BCP).

Escobar Y, Mañas A, Juliá J, Gálvez R, Zaragozá F, Margarit C, López R, Casas A, Antón A, Cruz JJ.

Clin Transl Oncol. 2013 Jul;15(7):526-34. doi: 10.1007/s12094-012-0981-1. Epub 2012 Dec 21. Review.

PMID:
23263914
13.

Newer generation fentanyl transmucosal products for breakthrough pain in opioid-tolerant cancer patients.

Elsner F, Zeppetella G, Porta-Sales J, Tagarro I.

Clin Drug Investig. 2011;31(9):605-18. doi: 10.2165/11592910-000000000-00000. Review.

PMID:
21819159
14.

Fentanyl for breakthrough pain: a systematic review.

Davis MP.

Expert Rev Neurother. 2011 Aug;11(8):1197-216. doi: 10.1586/ern.11.63. Review.

PMID:
21797660
15.

Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain.

Bulloch MN, Hutchison AM.

Expert Rev Clin Pharmacol. 2013 Jan;6(1):9-22. doi: 10.1586/ecp.12.69.

PMID:
23272789
16.

[Cancer breakthrough pain. Indications for rapidly effective opioids].

Kessler J, Bardenheuer HJ.

Anaesthesist. 2011 Jul;60(7):674-82. doi: 10.1007/s00101-011-1868-1. Review. German.

PMID:
21491140
17.

[Fentanyl: fast and furious?].

Meissner W, Sabatowski R.

Anaesthesist. 2013 Jun;62(6):429-30. doi: 10.1007/s00101-013-2195-5. German. No abstract available.

PMID:
23748418
18.

Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.

Núñez-Olarte JM, Alvarez-Jiménez P.

J Pain Symptom Manage. 2011 Dec;42(6):e6-8. doi: 10.1016/j.jpainsymman.2011.07.006. Epub 2011 Nov 1. No abstract available.

PMID:
22048003
19.

Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain.

Ruggeri M, Turriziani A, Oradei M.

Expert Rev Pharmacoecon Outcomes Res. 2014 Jun;14(3):459-64. doi: 10.1586/14737167.2014.904750. Epub 2014 Apr 4.

PMID:
24702061
20.

[Cancer patient with breakthrough pain].

Elsner F, Pastrana T.

MMW Fortschr Med. 2013 Feb 21;155(3):48-9. German. No abstract available.

PMID:
23573769
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk